Invention Grant
- Patent Title: Substituted quinazolines for inhibiting kinase activity
-
Application No.: US16188852Application Date: 2018-11-13
-
Publication No.: US10653701B2Publication Date: 2020-05-19
- Inventor: Xiangping Qian , Yong-Liang Zhu
- Applicant: NeuPharma, Inc.
- Applicant Address: US CA Foster City
- Assignee: NEUPHARMA, INC.
- Current Assignee: NEUPHARMA, INC.
- Current Assignee Address: US CA Foster City
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K31/517
- IPC: A61K31/517 ; A61K31/553 ; A61K31/5377 ; A61K45/06 ; C07D239/84 ; C07D401/04 ; C07D401/12 ; C07D401/14 ; C07D403/04 ; C07D403/12 ; C07D405/12 ; C07D413/12 ; C07D471/04 ; C07C57/145 ; C12Q1/6886 ; G01N33/574
Abstract:
Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.
Public/Granted literature
- US20190307767A1 SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY Public/Granted day:2019-10-10
Information query
IPC分类:
